Increasingly complex monoclonal antibody molecules will require the right “tool box” for scaling up manufacturing.
Andy Racher
Advertisement
Articles by Andy Racher
Advertisement
Latest Updated Articles
Complex and Customized: Manufacturing New Molecular FormatsPublished: April 15th 2019 | Updated:
Advertisement
Advertisement
Trending on BioPharm International
1
Implications of FDA’s New Draft Guidance on Innovative Trial Design for Rare-Disease CGTs
2
White House, Pfizer Reach First MFN Pricing Agreement; Who's Next?
3
New FDA Guidance Utilizes Real-World Data and AI for Postmarket CGT Surveillance
4
The Importance of Innovation in Mission-Critical BioPharma Cold Storage
5
